TABLE 1.
QTL iD | Chromosome (Mb) | Phenotype(s) (days postinfection [dpi]) | Haplotype(s)a | Phenotypic variation (%) |
---|---|---|---|---|
CC011xCC074-F2, significant loci | ||||
HrS24 | chr4: 32.95–114.54 | Mortality | CC011: G, H, C CC074: A/H, A/D, D, E, F |
ORb 4.34 |
HrS25 | chr4: 6.38–17.97 | Weight loss in males (4 dpi) | CC011: G, B CC074: A |
12.57% |
HrS26 | chr9: 74.94–124.06 chr9: 117.38–124.07 chr9: 116.24–124.07 chr9: 111.54–122.63 chr9: 111.54–122.63 |
Mortality Congestion score (4 dpi) PenH (2 dpi) Periph. neutrophils (4 dpi) Periph. lymphocytes (4 dpi) |
CC011: B, G CC074: A |
ORb 3.15 10.24% 7.76% 11.8% 12.39% |
HrS27 | chr11: 26.44–80.76 chr11: 17.89–80.76 |
Periph. neutrophils (4 dpi) Periph. lymphocytes (4 dpi) |
CC011: H, B, H CC074: C |
5.5% 5.6% |
HrS28 | chr15: 58.66–74.04 | PenH (2 dpi) | CC011: H | 8.48% |
CC074: B | ||||
CC011xCC074-F2, suggestive loci | ||||
HrS29 | chr3: 7.2–159.1 | Mortality (4 dpi) Congestion score (4 dpi) |
CC011: C, C/D, D, A, D, E CC074: D, H, B, B/F, B/D, B |
|
HrS30 | chr9: 28.2–124.1 | Weight loss (4 dpi) Mortality (4 dpi) Weight loss females (4 dpi) |
CC011: B, G, B CC074: A |
|
HrS31 | chr13: 31.9–90.3 | Hemorrhage (4 dpi) Periph. monocytes (4 dpi) |
CC011: B, C CC074: G, D |
|
HrS32 | chr14: 33.8–114.8 | PenH (2 dpi) | CC011: C CC074: E, H, G |
|
HrS33 | chrX: 6.2–93.9 | Rpef (2 dpi) Periph. neutrophils (2 dpi) |
CC011: E, C/E, E, A, G CC074: G, B |
Haplotype effects are described for each QTL. For the Pre-CC and CC-RIX, the haplotypes are separated based on the allele effect splits between founder haplotypes (A, A/J; B, C57BL/6J; C, 129S1/SvImJ; D. NOD/ShILtJ; E, NZO/HiLtJ; F, CAST/EiJ; G, PWK/PhJ; H, WSB/EiJ). In CC-F2 crosses, the haplotypes listed are those present in the given parent strains from the proximal to distal ends of each region. Rpef, ratio of time to peak expiratory flow relative to total expiratory time.
QTL influencing mortality calculate an odds ratio (OR) for disease rather than a % of variation explained. For both the CC-RIX and the CC-F2, OR for specific loci are calculated with a full model of all mortality loci, to better estimate their independent effects.